Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Rein

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Molecular Evolution|November 28, 1974
Some remarks on parity violating effects of intramolecular interactionsD W Rein
The Hastings Center Report|June 17, 2005
FDA and the life-sciences industry: business as usual?"Bert W Rein
International Clinical Psychopharmacology|May 1, 1997
Clinical update on amisulpride in deficit schizophreniaW Rein, S Turjanski
Modern Problems of Pharmacopsychiatry|January 1, 1983
Rater training for the use of psychiatric rating scales: recommendations for the AMDP-SystemH Heimann, W Rein
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 18, 2003
[Hereditary cerebral arteriopathy]W Rein Gustavsen, Kristin Eiklid
Acta Psychiatrica Scandinavica|August 8, 1998
Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study GroupA Puech, O Fleurot, W Rein
Acta Psychiatrica Belgica|March 1, 1987
[Evaluation of pathogenic events in psychiatric patients using the anamnestic fiches of the AMDP system]W Rein, G Fitzner, H Heimann
Acta Psychiatrica Belgica|July 1, 1982
[1st results of the DiaSiKa diagnostic system]W Rein, S Piree, P Pichot
L'Encephale|June 1, 1996
[Methodological constraints in evaluating anti-deficit effects]P Boyer, Y Lecrubier, W Rein
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|September 1, 1987
[Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline]H Giedke, H Heimann, W Rein
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Molecular Evolution|November 28, 1974
Some remarks on parity violating effects of intramolecular interactionsD W Rein
The Hastings Center Report|June 17, 2005
FDA and the life-sciences industry: business as usual?"Bert W Rein
International Clinical Psychopharmacology|May 1, 1997
Clinical update on amisulpride in deficit schizophreniaW Rein, S Turjanski
Modern Problems of Pharmacopsychiatry|January 1, 1983
Rater training for the use of psychiatric rating scales: recommendations for the AMDP-SystemH Heimann, W Rein
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 18, 2003
[Hereditary cerebral arteriopathy]W Rein Gustavsen, Kristin Eiklid
Acta Psychiatrica Scandinavica|August 8, 1998
Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study GroupA Puech, O Fleurot, W Rein
Acta Psychiatrica Belgica|March 1, 1987
[Evaluation of pathogenic events in psychiatric patients using the anamnestic fiches of the AMDP system]W Rein, G Fitzner, H Heimann
Acta Psychiatrica Belgica|July 1, 1982
[1st results of the DiaSiKa diagnostic system]W Rein, S Piree, P Pichot
L'Encephale|June 1, 1996
[Methodological constraints in evaluating anti-deficit effects]P Boyer, Y Lecrubier, W Rein
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|September 1, 1987
[Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline]H Giedke, H Heimann, W Rein
Pageof 3